CLEAR CELL ADENOCARCINOMA OF OVARY

Clinical trials for CLEAR CELL ADENOCARCINOMA OF OVARY explained in plain language.

Never miss a new study

Get alerted when new CLEAR CELL ADENOCARCINOMA OF OVARY trials appear

Sign up with your email to follow new studies for CLEAR CELL ADENOCARCINOMA OF OVARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New immune therapy trial offers hope for Tough-to-Treat gynecologic cancers

Disease control Recruiting now

This study is testing an experimental immunotherapy drug called lorigerlimab for women with advanced ovarian and other gynecologic cancers that have stopped responding to standard platinum-based chemotherapy. About 60 participants will receive the drug through an IV every three w…

Matched conditions: CLEAR CELL ADENOCARCINOMA OF OVARY

Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

CLEAR CELL ADENOCARCINOMA OF OVARY

Get alerted when new CLEAR CELL ADENOCARCINOMA OF OVARY trials appear

New immune therapy trial offers hope for Tough-to-Treat gynecologic cancers